OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
934058

Aso International Inc

Medical Equipment, Supplies & DistributionVerified

Aso International Inc maintains a strong liquidity position, with a current ratio of 7.01, indicating a high ability to meet short-term obligations. The company holds JPY 1,873,428,000 in cash and equivalents, representing 64.6% of its total assets, and has no long-term debt, which further supports its liquidity profile. This liquidity is supported by a total equity of JPY 2,588,630,000, with total liabilities at JPY 369,765,000, resulting in a debt-to-equity ratio of 0. In terms of profitability, Aso International Inc reports a return on equity (ROE) of 3.97% and a return on assets (ROA) of 3.47%. These figures are below the industry median for ROE and ROA in the Medical Equipment, Supplies & Distribution sector, suggesting that the company is underperforming relative to its peers in terms of capital efficiency and asset utilization. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic breakdown provided in the available data. This lack of geographic diversification may expose the company to regional economic or regulatory risks, though the extent of such exposure is not quantified in the available data. Looking ahead, Aso International Inc is projected to grow its revenue from JPY 8,743,350,000 in the current fiscal year to JPY 4,100,000,000 in the next fiscal year, representing a decline of 53.0%. This significant drop in revenue expectations may be attributed to market saturation, competitive pressures, or a shift in demand for its products and services. The company's risk profile is characterized by low liquidity and dilution risk, with no immediate filing-based flags detected. The absence of long-term debt and the high cash reserves reduce the likelihood of financial distress. However, the potential for dilution remains low, as the number of shares outstanding has not changed between basic and diluted shares. Recent events, including analyst estimates and actual performance, indicate a mixed outlook. The last actual EPS was 44.90 JPY, compared to a mean estimate of 50.00 JPY, suggesting a slight underperformance. Similarly, the last actual revenue of JPY 3,796,450,000 fell short of the mean estimate of JPY 4,100,000,000, indicating a need for the company to address potential operational or market challenges.

30-day price · 9340+22.00 (+3.3%)
Low$673.00High$704.00Close$697.00As of16 May, 00:00 UTC
Profile
CompanyAso International Inc
Ticker9340.T
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Aso International Inc provides medical equipment, supplies, and distribution services in the healthcare sector.

Classification. The company is classified under the Healthcare Services & Equipment business sector and the Medical Equipment, Supplies & Distribution industry with a confidence level of 0.92.

Aso International Inc maintains a strong liquidity position, with a current ratio of 7.01, indicating a high ability to meet short-term obligations. The company holds JPY 1,873,428,000 in cash and equivalents, representing 64.6% of its total assets, and has no long-term debt, which further supports its liquidity profile. This liquidity is supported by a total equity of JPY 2,588,630,000, with total liabilities at JPY 369,765,000, resulting in a debt-to-equity ratio of 0. In terms of profitability, Aso International Inc reports a return on equity (ROE) of 3.97% and a return on assets (ROA) of 3.47%. These figures are below the industry median for ROE and ROA in the Medical Equipment, Supplies & Distribution sector, suggesting that the company is underperforming relative to its peers in terms of capital efficiency and asset utilization. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic breakdown provided in the available data. This lack of geographic diversification may expose the company to regional economic or regulatory risks, though the extent of such exposure is not quantified in the available data. Looking ahead, Aso International Inc is projected to grow its revenue from JPY 8,743,350,000 in the current fiscal year to JPY 4,100,000,000 in the next fiscal year, representing a decline of 53.0%. This significant drop in revenue expectations may be attributed to market saturation, competitive pressures, or a shift in demand for its products and services. The company's risk profile is characterized by low liquidity and dilution risk, with no immediate filing-based flags detected. The absence of long-term debt and the high cash reserves reduce the likelihood of financial distress. However, the potential for dilution remains low, as the number of shares outstanding has not changed between basic and diluted shares. Recent events, including analyst estimates and actual performance, indicate a mixed outlook. The last actual EPS was 44.90 JPY, compared to a mean estimate of 50.00 JPY, suggesting a slight underperformance. Similarly, the last actual revenue of JPY 3,796,450,000 fell short of the mean estimate of JPY 4,100,000,000, indicating a need for the company to address potential operational or market challenges.
Key takeaways
  • Aso International Inc has a strong liquidity position with a current ratio of 7.01 and no long-term debt.
  • The company's ROE and ROA are below industry medians, indicating underperformance in capital efficiency and asset utilization.
  • Revenue is concentrated in a single business segment, with no geographic diversification disclosed.
  • Analyst estimates suggest a significant decline in revenue for the next fiscal year, from JPY 8.74 billion to JPY 4.1 billion.
  • The company faces low liquidity and dilution risk, with no immediate filing-based flags detected.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$874.3M
Gross profit$404.2M
Operating income$149.1M
Net income$102.7M
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets$2.96B
Total liabilities$369.8M
Total equity$2.59B
Cash & equivalents$1.87B
Long-term debt$0.00
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$3.06B$626.5M$411.2M$418.4M
FY-3$3.12B$511.3M$351.8M$341.3M
FY-2$3.19B$508.6M$338.2M$193.6M
FY-1$3.54B$545.8M$386.4M$280.3M
FY0$3.80B$635.9M$438.6M$185.4M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$2.04B$1.30B$1.21B
FY-3$2.19B$1.55B$1.29B
FY-2$2.83B$2.47B$1.73B
FY-1$3.18B$2.76B$1.90B
FY0$3.33B$2.93B$1.95B
PeriodOCFCapExFCFSBC
FY-4$385.1M-$35.6M$418.4M
FY-3$246.7M-$49.4M$341.3M
FY-2$245.7M-$73.5M$193.6M
FY-1$437.2M-$50.7M$280.3M
FY0$473.3M-$29.2M$185.4M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$874.3M$149.1M$102.7M
FQ-6$955.1M$184.4M$164.3M
FQ-5$916.3M$135.9M$78.5M
FQ-4$947.7M$152.2M$122.2M
FQ-3$952.9M$168.2M$106.2M
FQ-2$979.5M$179.6M$131.6M
FQ-1$1.00B$150.3M$110.0M
FQ0$1.02B$169.9M$125.8M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$2.96B$2.59B$1.87B
FQ-6$3.18B$2.76B$1.90B
FQ-5$2.98B$2.67B$1.72B
FQ-4$3.18B$2.70B$1.93B
FQ-3$3.11B$2.80B$1.79B
FQ-2$3.33B$2.93B$1.95B
FQ-1$3.30B$2.94B$1.39B
FQ0$3.49B$2.94B$1.40B
PeriodOCFCapExFCFSBC
FQ-7
FQ-6$437.2M-$50.7M
FQ-5
FQ-4$222.7M-$16.8M
FQ-3
FQ-2$473.3M-$29.2M
FQ-1
FQ0$193.8M-$9.8M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.59B
Net cash$1.87B
Current ratio7.0
Debt/Equity0.0
ROA3.5%
ROE4.0%
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 369 companies
Metric9340Activity
Op margin17.1%3.9% medp25 -31.3% · p75 14.4%top quartile
Net margin11.7%2.4% medp25 -30.5% · p75 11.1%top quartile
Gross margin46.2%46.7% medp25 28.2% · p75 63.1%below median
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-4.8% medp25 -11.6% · p75 -2.4%
Debt / equity0.0%17.9% medp25 2.7% · p75 52.2%bottom quartile
Observations
IR observations
Mean EPS estimate50.00 JPY
Last actual EPS44.90 JPY
Mean revenue estimate4,100,000,000 JPY
Last actual revenue3,796,450,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-11 01:32 UTC#952b30a1
Market quoteclose JPY 684.00 · shares 0.01B diluted
no public URL
2026-05-05 04:43 UTC#ef58702f
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 04:56 UTCJob: 97e27a7f